Responses
Colorectal cancer
Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual disease
Compose a Response to This Article
Other responses
No responses have been published for this article.